🫀 CHA2DS2-VASc Calculator

Atrial fibrillation lets blood pool and clot in the heart's upper chambers, and those clots cause strokes. The CHA2DS2-VASc score, from Lip and colleagues in 2010, weighs the risk factors that predict which AFib patients actually stroke: heart failure, hypertension, age, diabetes, prior clots, vascular disease, and sex. The total, 0 to 9, maps to an annual stroke rate that drives the anticoagulation decision. Check your factors above.

How to Use This Calculator

Check each risk factor that applies. The score, annual stroke rate, and anticoagulation guidance appear.

The Score and the Stroke Rates

The mnemonic reads: Congestive heart failure, Hypertension, Age 75+ (2), Diabetes, Stroke/TIA (2), Vascular disease, Age 65-74, Sex category female. Age and prior stroke carry double weight because they dominated the original Euro Heart Survey data. Female sex counts as a risk modifier rather than a standalone reason to anticoagulate, which is why guidelines treat a score of 1 differently in women.

The stroke rates come from the original validation cohort of AFib patients not on anticoagulation. They are the numbers the guidelines were built on: at 0 the risk is negligible and blood thinners' bleeding risk outweighs benefit; at 2+ the stroke risk clearly exceeds bleeding risk for most patients, so oral anticoagulation is recommended. Score 1 is the judgment zone where the clinician weighs the individual.

Worked Example

A 72-year-old woman with hypertension and diabetes: age 65-74 (1) + female (1) + hypertension (1) + diabetes (1) = 4, about 4.0 percent annual stroke risk without anticoagulation. Guidelines recommend oral anticoagulation here. Contrast a 58-year-old man with hypertension alone: 1 point, about 1.3 percent, the discussion zone. And a 78-year-old man with prior stroke: age 75+ (2) + stroke (2) = 4 before counting anything else, already at the treat threshold from two factors. The double-weighted items do the heavy lifting.

Anticoagulation: What the Score Decides

Score 0 (men) or 1 (women, sex point only): no blood thinner needed. Score 1 (men) or 2 (women): consider anticoagulation based on the full picture. Score 2+ (men) or 3+ (women): oral anticoagulation recommended, usually a DOAC (apixaban, rivaroxaban, dabigatran, edoxaban) rather than warfarin for most patients. DOACs beat warfarin on convenience (no INR monitoring, fewer food interactions) and slightly on safety, though warfarin remains essential for mechanical valves and severe mitral stenosis.

Bleeding risk gets its own score, HAS-BLED, and high bleeding risk does not usually cancel anticoagulation; it prompts fixing reversible factors (alcohol, NSAIDs, uncontrolled hypertension) and closer follow-up. The net-benefit math favors anticoagulation for the vast majority of score 2+ patients, because strokes disable and bleeds, while serious, are more often manageable. Aspirin alone is not an alternative: it prevents far fewer strokes with nearly as much bleeding risk.

Beyond the Score

CHA2DS2-VASc guides whether to anticoagulate, not how well controlled the AFib is: rate control, rhythm control, and lifestyle (weight loss, sleep apnea treatment, alcohol reduction) run in parallel. Newer refinements like CHA2DS2-VA (dropping the sex criterion) are being adopted in some guidelines, reflecting evidence that female sex alone adds little. And the score is reassessed over time: birthdays add points, and a patient at 1 today may be at 2 next year. If you have AFib, knowing your own score turns the anticoagulation conversation from a directive into a discussion.

Related Calculators

Keep exploring: try our cardiovascular risk and BMI calculator for the next piece of the picture.

For informational purposes only, not medical advice. Consult a healthcare professional.